Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VENLAFAXINE Cause Product administration error? 69 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Product administration error have been filed in association with VENLAFAXINE (Venlafaxine Hydrochloride). This represents 0.1% of all adverse event reports for VENLAFAXINE.

69
Reports of Product administration error with VENLAFAXINE
0.1%
of all VENLAFAXINE reports
5
Deaths
42
Hospitalizations

How Dangerous Is Product administration error From VENLAFAXINE?

Of the 69 reports, 5 (7.2%) resulted in death, 42 (60.9%) required hospitalization, and 9 (13.0%) were considered life-threatening.

Is Product administration error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VENLAFAXINE. However, 69 reports have been filed with the FAERS database.

What Other Side Effects Does VENLAFAXINE Cause?

Drug ineffective (5,408) Toxicity to various agents (3,917) Nausea (2,989) Completed suicide (2,929) Headache (2,668) Dizziness (2,426) Off label use (2,310) Overdose (2,220) Intentional overdose (2,187) Fatigue (2,153)

What Other Drugs Cause Product administration error?

HYDROXYPROGESTERONE CAPROATE (972) ACETAMINOPHEN (666) CENEGERMIN-BKBJ (613) LEUPROLIDE (595) EVOLOCUMAB (565) ADALIMUMAB (543) METHYLPHENIDATE (414) OLMESARTAN MEDOXOMIL (314) ASPIRIN (241) SECUKINUMAB (225)

Which VENLAFAXINE Alternatives Have Lower Product administration error Risk?

VENLAFAXINE vs VENTAVIS VENLAFAXINE vs VENTOLIN VENLAFAXINE vs VENTOLIN HFA VENLAFAXINE vs VERAPAMIL VENLAFAXINE vs VERICIGUAT

Related Pages

VENLAFAXINE Full Profile All Product administration error Reports All Drugs Causing Product administration error VENLAFAXINE Demographics